The Boston Scientific transvaginal mesh class action settlement includes multiple settlements totaling over $400 million, with the largest being a $188.6 million multistate settlement resolving deceptive marketing allegations across 47 states and the District of Columbia. Boston Scientific, a major medical device manufacturer, faced widespread litigation from tens of thousands of women who experienced serious complications from the company’s pelvic floor support devices, including chronic pain, erosion, infection, and sexual dysfunction. The settlement resolved one of the largest product liability cases against a medical device company in recent history. This settlement emerged from a wave of litigation that began in the early 2010s.
Women who received transvaginal mesh implants for pelvic organ prolapse or stress urinary incontinence discovered that the devices often failed, required multiple surgeries to remove, and caused debilitating complications. Boston Scientific, along with other manufacturers like C.R. Bard and Ethicon, faced thousands of individual lawsuits consolidated into federal multidistrict litigations (MDLs). The company’s extensive settlement activity demonstrates both the severity of the injuries and the company’s liability for failing to adequately warn patients about the risks.
Table of Contents
- How Much Has Boston Scientific Paid in Transvaginal Mesh Settlements?
- Timeline of Boston Scientific Settlements and Legal Developments
- What Boston Scientific Transvaginal Mesh Products Were Involved?
- Who Qualifies for Boston Scientific Mesh Settlements and How to File Claims?
- Common Injuries from Boston Scientific Transvaginal Mesh Implants
- Recent Boston Scientific Lawsuits and Ongoing Litigation
- The Broader Transvaginal Mesh Litigation Landscape
- Conclusion
How Much Has Boston Scientific Paid in Transvaginal Mesh Settlements?
Boston Scientific has paid over $400 million total to resolve vaginal mesh lawsuits, making it one of the highest-paying manufacturers in this litigation. The largest settlement came in 2020 when the company agreed to pay $188.6 million to resolve allegations with 47 states and the District of Columbia, focusing on deceptive marketing practices. An earlier settlement in October 2018 resolved approximately 50,000 individual lawsuits for $189 million, representing one of the largest injury settlements in medical device litigation. These figures dwarf many settlements in other product liability cases—for perspective, most pharmaceutical settlements typically range from $50 million to $200 million, making the transvaginal mesh cases exceptionally expensive for manufacturers.
In addition to U.S. settlements, Boston Scientific also faced international liability. In March 2023, the company agreed to a $105 million federal court-approved settlement in Australia, demonstrating that transvaginal mesh injuries prompted litigation in multiple countries. The company also resolved an earlier settlement of nearly 3,000 lawsuits in April 2015 for $119 million, establishing early precedent for the scale of damages in these cases. These settlements are not final payments to individual claimants but rather settlement pools, with individual awards varying based on the severity of injuries and specific product involved.
Timeline of Boston Scientific Settlements and Legal Developments
The Boston Scientific transvaginal mesh litigation evolved over more than a decade, with major settlements marking different phases of the litigation. The first significant settlement came in 2015, when Boston Scientific paid $119 million to settle approximately 3,000 lawsuits filed by women injured by various mesh products. This early settlement signaled that juries were finding the company liable and that mass litigation was becoming inevitable. Over the next three years, the volume of claims against the company continued to grow exponentially, as women learned about the risks from news coverage and advertising by mass tort law firms.
The largest settlements came between 2018 and 2020. The October 2018 settlement of $189 million represented a major turning point, as it resolved an estimated 50,000 pending lawsuits at once. This settlement was significant because it moved thousands of cases out of active litigation simultaneously. Two years later, the $188.6 million multistate settlement in 2020 added another massive settlement, this time focusing specifically on deceptive marketing practices. However, a critical limitation of these large settlements is that they do not prevent new lawsuits—women who were injured but had not yet filed claims at the time of settlement were sometimes excluded, forcing some victims to pursue separate litigation after the fact.
What Boston Scientific Transvaginal Mesh Products Were Involved?
Boston Scientific manufactured several transvaginal mesh products that were the subject of litigation, including the Pinnacle pelvic floor replacement kit and the Obtryx II mid-urethral sling. The Pinnacle device, used to treat pelvic organ prolapse, became particularly problematic. In May 2025, a federal court in Miami awarded $26.7 million to four women in a verdict against Boston Scientific specifically for Pinnacle defects, with the court finding that the product had poor design and inadequate risk warnings.
This recent verdict shows that litigation continues against specific products even as older MDLs close. The Obtryx II mid-urethral sling is currently the subject of new litigation in the District of Massachusetts, with recent lawsuits alleging that Boston Scientific’s version continues to cause serious injuries decades after its introduction. The sling is designed to support the urethra and reduce stress urinary incontinence, but women reported erosion through vaginal tissue, chronic pelvic pain, and vaginal bleeding. These two products represent different types of mesh devices—one for prolapse and one for incontinence—demonstrating that the injury problem was systemic across Boston Scientific’s entire mesh product line, not isolated to a single device.
Who Qualifies for Boston Scientific Mesh Settlements and How to File Claims?
Eligibility for Boston Scientific mesh settlements depends on when the settlement was reached and which product you received. For the major settlements already concluded, the general criteria include having received a Boston Scientific transvaginal mesh implant, experiencing complications from the device, and filing a claim before the settlement’s claims deadline. Each settlement had its own claims period, and this is a critical limitation: women whose devices failed after a settlement’s deadline period had closed sometimes could not recover from that settlement, forcing them to file individual lawsuits instead.
The claims process typically involves submitting documentation to a claims administrator, including medical records showing the implant date and the complications experienced. In the New Jersey settlements concluded in October 2025, nearly 30 women received settlements, with 38 additional lawsuits still in the fact-gathering stage. These recent filings demonstrate that women are still discovering injury from these devices and pursuing compensation. For current and potential claimants, the key action is to gather all medical records related to the implant surgery and any subsequent revision surgeries, as claims typically require documentation of multiple surgeries, medical treatment, and expert medical testimony about causation.
Common Injuries from Boston Scientific Transvaginal Mesh Implants
Women injured by Boston Scientific transvaginal mesh experienced severe, sometimes permanent, complications that often required multiple surgeries to manage. The most common injuries include vaginal mesh erosion (the material wearing through vaginal tissue), chronic pelvic pain, persistent infection, vaginal bleeding, painful intercourse, and neurological damage. In the May 2025 Miami verdict awarding $26.7 million, the court found that women experienced significant erosion issues with the Pinnacle product, with some erosions causing debilitating pain and loss of sexual function.
A critical limitation in many cases is that the connection between the mesh and the patient’s injury is not always immediately obvious. Complications from transvaginal mesh can develop years after implantation, sometimes when the woman’s body has partially rejected or eroded the synthetic material. This delay makes it difficult for patients to connect their symptoms to the mesh, and it also complicates litigation because Boston Scientific argues that other factors may have caused the injury. Additionally, not all women with mesh experience serious complications—some patients have tolerated the devices well—which is why individual settlements vary so widely based on the specific injuries documented in each case.
Recent Boston Scientific Lawsuits and Ongoing Litigation
Despite major settlements in 2018 and 2020, Boston Scientific continues to face new lawsuits. The most prominent recent development is a new lawsuit filed in the District of Massachusetts alleging that the Obtryx II mid-urethral sling continues to cause serious injuries including erosion, chronic pelvic pain, and vaginal bleeding. This lawsuit is significant because it shows that Boston Scientific’s mesh products are still injuring women today, not just cases from devices implanted a decade ago.
The company has not resolved these Obtryx II claims as part of its earlier settlements. In October 2025, women in New Jersey achieved settlements for nearly 30 cases, with an additional 38 lawsuits still in the discovery and fact-gathering stage. These New Jersey cases represent the shift in litigation activity away from the large federal multidistrict litigations (MDLs) that dominated 2010-2022, toward individual state court litigation. Most federal MDLs related to transvaginal mesh concluded by 2022, but this does not mean litigation has ended—it has simply moved to state courts where individual juries decide cases one at a time rather than through consolidated proceedings.
The Broader Transvaginal Mesh Litigation Landscape
Boston Scientific was not alone in facing transvaginal mesh litigation. Over 100,000 women filed vaginal mesh lawsuits between 2010 and 2022, and across all manufacturers—including C.R. Bard, Ethicon (Johnson & Johnson), and others—over $8 billion in settlements and jury verdicts have been paid out. This massive litigation wave prompted the FDA to conduct a safety review of transvaginal mesh devices in 2016, ultimately restricting their use and requiring stronger warning labels.
Boston Scientific’s settlements represent a significant portion of this broader $8 billion, indicating that the company was one of the most frequently implicated manufacturers. Looking forward, transvaginal mesh litigation is likely to continue at a slower pace in state courts. The closure of federal MDLs does not prevent new lawsuits from being filed, and as more women discover late-onset complications from mesh implanted years ago, litigation will continue. The shift to state court litigation means that outcomes may vary significantly by jurisdiction—verdicts that succeed in one state may not succeed in another, leading to inconsistent compensation for injured women.
Conclusion
The Boston Scientific transvaginal mesh class action settlement represents one of the largest product liability cases against a medical device manufacturer, with the company paying over $400 million to resolve tens of thousands of lawsuits. The largest settlements—$189 million in 2018 and $188.6 million in 2020—resolved massive numbers of claims at once, but significant limitations apply, including strict claims deadlines that excluded some injured women. Boston Scientific’s Pinnacle and Obtryx II products particularly caused severe complications including erosion, chronic pain, and infection, which the company allegedly failed to adequately warn patients about beforehand.
If you received a Boston Scientific transvaginal mesh implant and experienced complications, review the claims deadlines for settlements that may have been concluded and gather your medical records immediately. With federal MDL litigation largely concluded as of 2022, remaining cases are being pursued through state courts and individual litigation, which can be more unpredictable but may result in larger jury awards. Contact a mass tort attorney experienced in transvaginal mesh cases to determine whether you qualify for any existing settlements or whether filing an individual lawsuit is your best option for compensation.